FDA Top Scientist Goodman Prioritizes "Strengthening Our Scientific Approach"
This article was originally published in The Tan Sheet
Executive Summary
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original focus: improving the agency's scientific capacity and integrity.
You may also be interested in...
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
A $25 million, cross-center scientific modernization effort proposed in FDA's fiscal 2011 budget targets gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology
FDA Reorganization Elevates Scientific And Food Safety Priorities
The FDA Commissioner says the realignment of four deputy-level offices in the Office of the Commissioner will streamline "common activities" and strengthen science and food safety
FDA Pursues Consumer Products With Questionable Flu Treatment Claims
FDA continues its efforts to protect consumers from the ongoing H1N1 flu outbreak, as well as from opportunistic marketers selling potentially deceptive "cures" for the virus